Untitled Document


*Current "Economic Issues in U.S. Healthcare" Breaking News* as of July 14, 2010**		Scrolling View Static View Subscribe to RSS feed

MedIntelliBlog^TM insights into intelligence WeirdMedical^TM anomalies for strange times MedIntelliBase^® 3-week free trial - pick your topic MIB Breaking News MIB Alerts MIB MarketTracks MIB EU 2010 MDD LitReview	Current News "Top Picks" by MIB Editors... Fear surrounds deal between nonprofit hospital, for-profit company FierceHealthcare, 2010-07-14 "As nonprofit hospitals become increasingly attractive to for-profit companies looking to capture..." U.S. Advisers Say Keep Glaxo's Avandia on Market Reuters via BNET, 2010-07-14 "U.S. health advisers said GlaxoSmithKline Plc's (GSK) diabetes drug Avandia should be allowed to..." Business versus Obama MarketWatch, 2010-07-14 "When in doubt, whine about the government. That seems to be the latest corporate strategy..." RXi Pharmaceuticals receives SBIR grant from National Institute of Allergy and Infectious Diseases Trading Markets, 2010-07-14 "RXi Pharmaceuticals Corporation, a RNAi-based therapeutic discovery and development company..."
	...for more Current News Click Here to view the "Full Breaking News Listing."
	Most Read News from Last Week... Obama bypasses Senate for new Medicare chief The Associated Press via The Seattle Times, 2010-07-07 Drug Prices in the US: Not So High After All? Corante, 2010-07-07 Domestic medical travel could ratchet up pressure on local providers FierceHealthcare, 2010-07-07 Generex Biotechnology Participates in Gateway to China Business Round Table Conference Market Watch, 2010-07-07
If you have any questions or comments about this service we welcome your feedback. Best regards - Jordan & Vicky Jordan Zornes -- Editor & Senior Analyst \| Phone 1-425.894.4147 \| jpz@medintellibase.com Vicky Hunsicker Sanko -- Senior Editor, President & CEO \| Office Phone – 1-425-869-8724 – Mobile Phone – 1-206-669-3053\| vhs@medintellibase.com *, ® - "The Next Phase" and "MedIntelliBase" are registered trademarks of The Next Phase Consultancy, Inc.